Effects of lidocaine infusion during experimental endotoxemia in horses

Journal of Veterinary Internal Medicine

Volumn 24, Issue 4, 2010, Pages 940-948

  Peiro J R ^a   Barnabe P A ^a   Cadioli, F A ^a   Cunha, F Q ^b   Lima, V M F ^a   Mendonca V H ^a   Santana, A E ^a   Malheiros, E B ^a   Perri, S H V ^a   Valadao C A A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Lipopolysaccharide; Peritoneal fluid; Polymorphonuclear cells

Indexed keywords

ANIMALIA; EQUIDAE;

ENDOTOXIN; LIDOCAINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTOXEMIA; HORSE; HORSE DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM;

ANIMALS; ENDOTOXEMIA; ENDOTOXINS; HORSE DISEASES; HORSES; INJECTIONS, INTRAVENOUS; LIDOCAINE; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956631942     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0555.x     Document Type: Article

References (61)

1. MacKay RJ, Merrit AM, Zertuche JM, et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991;52:533-538.
2. Kelmer G. Update on treatments for endotoxemia. Vet Clin North Am Equine Pract 2009;25:259-270.
3. Moore JN. Recognition and treatment of endotoxemia. Vet Clin North Am Equine Pract 1988;4:105-113.
4. Brianceau P, Chevalier H, Karas A, et al. Intravenous lidocaine and small-intestinal size, abdominal fluid, and outcome after colic surgery in horses. J Vet Intern Med 2002;16:736-741.
5. Malone E, Ensink J, Turner T, et al. Intravenous continuous infusion of lidocaine for treatment of equine ileus. Vet Surg 2006;35: 60-66.
6. MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980;56:203-209.
7. McCafferty DM, Sharkey KA, Wallace JL. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 1994;266:G560-G567.
8. Nellgård P, Jönsson A, Bojö L, et al. Small-bowell obstruction and the effects of lidocaine, atropine and hexamethonium on inflammation and fluid losses. Acta Anaesthesiol Scand 1996;40: 287-292.
9. Torfs S, Delesalle C, Dewulf J, et al. Risk factors for equine postoperative ileus and effectiveness of prophylactic lidocaine. J Vet Intern Med 2009;23:606-611.
10. Taniguchi T, Shibata K, Yamamoto K, et al. Lidocaine attenuates the hypothensive and inflammatory responses to endotoxemia in rabbits. Crit Care Med 1996;24:642-646.
11. Taniguchi T, Shibata K, Yamamoto K, et al. Effects of lidocaine administration on hemodynamics and cytokine responses to endotoxemia in rabbits. Crit Care Med 2000;28:755-759.
12. Clark ES, Moore JN. The effects of slow infusion of a low dosage of endotoxin in healthy horses. Equine Vet J Suppl 1989;7:33-37.
13. Parviainen AK, Barton MH, Norton NN. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am J Vet Res 2001;62:72-76.
14. Barton MH, Parviainen A, Norton N. Polymyxin B protects horses against induced endotoxemia in vivo. Equine Vet J 2004; 36:397-401.
15. Kelmer G, Doherty TJ, Elliott S, et al. Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse. Equine Vet J 2008;40:358-363.
16. Poulin Braim AE, MacDonald MH, Bruss ML, et al. Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia. Am J Vet Res 2009;70:1031-1042.
17. Wang LF, Tomita K, Sasaki T. Distinct tumor necrosis factoralpha responses in alveolar and peritoneal macrophages are associated with local levels of endotoxin. Inflammation 1998;22:447-457.
18. Valadão CAA, Peiró JR, Santana AE, et al. Evaluation of peritoneal fluid in horses with experimental endotoxemia. J Equine Vet Sci 1995;15:124-128.
19. Rosa PCS, Peiró JR, Campebell RC, et al. Effects of diclofenac and dexamethasone on horse experimental endotoxemia. Arq Bras Med Vet Zootec 2003;55:279-286.
20. Campebell RC, Peiró JR, Rosa PCS, et al. Endotoxemia por lipopolissacarídeo de Escherichia coli, em eqüinos: Efeitos de antiinflamatórios nas concentrações sérica e peritoneal do fator de necrose tumoral alfa (TNF-α). [Escherichia coli lipopolisacharide (LPS) induced endotoxemia in horses: effects of anti-inflammatory drugs on serum and peritoneal tumor necrosis factor alpha (TNF-α) concentrations]. Arq Bras Med Vet Zoot 2007;59:837-843.
21. Peiró JR, Campebell RC, Santana AE, et al. Clinical and laboratory evaluation of horses after intraperitoneal injection of lipopolysaccharide (LPS). J Equine Vet Sci 1999;19:187-191; [published erratum appears in J Eq Vet Sci 2000;20:44].
22. Feary DJ, Mama KR, Wagner AE, et al. Influence of general anesthesia on pharmacokinetics of intravenous lidocaine infusion in horses. Am J Vet Res 2005;66:574-580.
23. Moore JN, Norton N, Barton MH, et al. Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine Vet J 2007;39:243-248.
24. Feldman BF, Zinkl JG, Jain NC. Schalm's Veterinary Hematology, 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000:3-11.
25. Morris DD, Crowe N, Moore JN. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am J Vet Res 1990; 51:1935-1940.
26. Schmidt HH, Wilke P, Evers B, et al. Enzymatic formation of nitrogen oxides from L-arginine in bovine brain cytosol. Biochem Biophys Res Commun 1989;165:284-291.
27. Green LC, Ruiz de Luzuriaga K, Wagner DA, et al. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981;78:7764-7768.
28. Meyers KM, Reed SM, Keck M. Circulating endotoxin-like substance(s) and altered hemostasis in horses with gastrointestinal disorders. Am J Vet Res 1982;43:2233-2235.
29. Moore JN. Introduction to endotoxemia. AAEP Proceedings 1995;41:100-102.
30. Burrows GE. Equine Escherichia coli endotoxemia: Comparison of intravenous and intraperitoneal endotoxin administration. Am J Vet Res 1979;40:991-998.
31. Chang SW, Feddrsen CO, Henson PM, et al. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987;79:1498-1509.
32. Barton MH, Moore JN, Norton N. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. Am J Vet Res 1997;58:1300-1307.
33. Sundgren-Andersson AK, Ostlund P, Bartfai T. IL-6 is essential in TNF-α-induced fever. Am J Physiol 1998;275:R2028-R2034.
34. Plata-Salamán CR, Borkoski JP. Centrally administered bacterial lipopolysaccharide depresses feeding in rats. Pharmacol Biochem Behav 1993;46:787-791.
35. Ogle K, Guo X, Hasselgren PO, et al. The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur J Surg 1997;163:45-51.
36. Barton MH, Collatos C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J Vet Intern Med 1999;13:457-464.
37. Bertone AL, Palmer JL, Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet Surg 2001;30:528-538.
38. Scheerlinck JY. Funcional and structural comparison of cytokines in different species. Vet Immunol Immunopathol 1999;72:39-44.
39. Cowell RL, Tyler RD. Diagnostic Cytology and Hematology of the Horse, 2nd ed. St Louis, MO: Mosby; 2002:127-162.
40. Peiró JR. Endotoxemia Experimental em Eqüinos: Avaliação Clínico-Laboratorial. Faculdade de Ciências Agrárias e Veterinárias, São Paulo State University (UNESP), Jaboticabal, 1997, 89pp. Masters Thesis.
41. Webel DM, Finck BN, Baker DH, et al. Time course of increased plasma cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of lipopolysaccharide. J Am Sci 1997;75:1514-1520.
42. Chandra R, Villanueva E, Feketova E, et al. Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: The effect of G6PD deficiency. J Leukoc Biol 2008;83:1541-1550.
43. Krabbe KS, Bruunsgaard H, Qvist J, et al. Activated T lymphocytes disappear from circulation during endotoxemia in humans. Clin Diagn Lab Immunol 2002;9:731-735.
44. Toft P, Lillevang ST, Tfnnesen E, et al. Redistribution of lymphocytes following E. coli sepsis. Scand J Immunol 1993;38: 541-545.
45. Ebdrup L, Krog J, Granfeldt A, et al. Dynamic expression of the signal regulatory protein a and CD18 on porcine PBMC during acute endotoxaemia. Scand J Immunol 2008;68:430-437.
46. Garma-Aviña A. Cytology of 100 samples of abdominal fluid from 100 horses with abdominal disease. Equine Vet J 1998;30:435-444.
47. Mendes LCN, Marques LC, Bechara GH, et al. Experimental peritonitis in horses: Peritoneal fluid composition. Arq Bras Med Vet Zootec 1999;51:217-221.
48. Rimbäck G, Cassuto J, Wallin G, et al. Inhibition of peritonitis by amide local anesthetics. Anesthesiology 1988;69:881-886.
49. Schmidt W, Schmidt H, Bauer H, et al. Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Anesthesiol 1997;87:617-624.
50. Grega GJ, Adamski SW. Effects of local mast cell degranulation on vascular permeability to macromolecules. Microcirc Endothelium Lymphatics 1991;7:267-291.
51. Wilson J, Gordon B. Equine colic: Interpreting the diagnostic tests. Vet Med 1987;82:629-645.
52. Collatos C, Barton MH, Moore JN. Fibrinolytic activity in plasma from horses with gastrointestinal diseases: Changes associated with diagnosis, surgery, and outcome. J Vet Intern Med 1995;9:18-23.
53. Joubert P, Silversides DW, Lavoie JP. Equine neutrophils express mRNA for tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-gamma. Equine Vet J 2001;33:730-733.
54. Chiang N, Schwab JM, Fredman G, et al. Anesthetics impact the resolution of inflammation. PLoS One 2008;3:e1879.
55. Juzwiak JS, Ragle CA, Brown CM, et al. The effect of repeated abdominocentesis on peritoneal fluid constituents in the horse. Vet Res Commun 1991;15:177-180.
56. Hawkins DL, MacKay RJ, MacKay SLD, et al. Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages. Vet Immunol Immunopathol 1998;66:1-10.
57. Bueno AC, Seahorn TL, Cornick-Seahorn J, et al. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Am J Vet Res 1999;60:969-976.
58. Mirza MH, Oliver JL, Seahorn TL, et al. Detection and comparison of nitric oxide in clinically normal horses and those with naturally acquired small intestinal strangulation obstruction. Can J Vet Res 1999;63:230-240.
59. Lavoie JP, Madigan JE, Cullor JS, et al. Haemodynamic, pathological, haematological and behavioural changes during endotoxin infusion in equine neonates. Equine Vet J 1990;22:23-29.
60. Froscher BG, Nagode LA. Origin and importance of increased alkaline phosphatase activity in peritoneal fluids of horses with colic. Am J Vet Res 1981;42:888-891.
61. Burrows GE. Endotoxaemia in the horse. Equine vet J 1981;13:89-94.